Kenneth Lieberman is a Nephrology physician affiliated with Hackensack University Medical Center. OpenAlex indexes 59 publications with 1,576 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
30 Prospect Ave
Humc - Pediatric Center
Hackensack, NJ 076011914
Telephone
551-996-8228Provider last certified this registry record 30 Sept 2022.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Calliditas Therapeutics US Inc.Program year20259 payments$12,902openpaymentsdata.cms.gov ↗
- Apellis Pharmaceuticals, Inc.Program year20255 payments$12,718openpaymentsdata.cms.gov ↗
- Travere Therapeutics, Inc.Program year202510 payments$10,491openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Kinase inhibitor100%Everolimus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Daratumumab for Treatment of Acute Antibody‐Mediated Rejection in a Pediatric Kidney Transplant Recipient
Pediatric Transplantation
2025 - Sparsentan (SPAR) vs. Irbesartan (IRB) in Pediatric Patients with FSGS in the Phase 3 DUPLEX Trial
Journal of the American Society of Nephrology
2025 - Sparsentan (SPAR) in Pediatric Patients with Rare Proteinuric Kidney Disease: Preliminary Findings from the EPPIK Study
Journal of the American Society of Nephrology
2024 - Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
New England Journal of Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Parrillo, MD
Hackensack University Medical Center
Andre Goy, MD
Hackensack University Medical Center
David Vesole, MD
Hackensack University Medical Center
Caron Rockman, MD
Hackensack University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”